TQQQ:NSD-ProShares UltraPro QQQ (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 69.6

Change

-2.37 (-3.29)%

Market Cap

USD 24.31B

Volume

0.04B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
BIB ProShares Ultra Nasdaq Biotech..

-1.53 (-2.46%)

USD 0.08B

ETFs Containing TQQQ

QQH HCM Defender 100 Index ET.. 18.74 % 0.00 %

-1.14 (0.00%)

USD 0.51B
ULTY Tidal Trust II 6.02 % 0.00 %

N/A

USD 0.04B
GTAA 0.00 % 1.25 %

N/A

N/A
HUSE 0.00 % 0.91 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -99.29% 50% F N/A F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.29% 50% F N/A F
Trailing 12 Months  
Capital Gain -99.04% 50% F N/A F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.04% 50% F N/A F
Trailing 5 Years  
Capital Gain -97.58% 50% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -97.58% 50% F 1% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 24.31B 100% F 96% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike